No abstract available
MeSH terms
-
Administration, Oral
-
Anticoagulants / adverse effects
-
Anticoagulants / therapeutic use*
-
Atrial Fibrillation / complications
-
Atrial Fibrillation / drug therapy*
-
Clinical Trials, Phase III as Topic
-
Embolism / prevention & control
-
Factor Xa Inhibitors
-
Humans
-
Pyrazoles / adverse effects
-
Pyrazoles / therapeutic use*
-
Pyridones / adverse effects
-
Pyridones / therapeutic use*
-
Stroke / etiology
-
Stroke / prevention & control*
-
Warfarin / adverse effects
-
Warfarin / therapeutic use
Substances
-
Anticoagulants
-
Factor Xa Inhibitors
-
Pyrazoles
-
Pyridones
-
apixaban
-
Warfarin